Vincerx Pharma Inc
NASDAQ:VINC
Balance Sheet
Balance Sheet Decomposition
Vincerx Pharma Inc
Vincerx Pharma Inc
Balance Sheet
Vincerx Pharma Inc
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
62
|
111
|
12
|
13
|
5
|
|
| Cash Equivalents |
62
|
111
|
12
|
13
|
5
|
|
| Short-Term Investments |
0
|
0
|
41
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
1
|
|
| Other Current Assets |
1
|
0
|
2
|
1
|
0
|
|
| Total Current Assets |
63
|
112
|
56
|
15
|
6
|
|
| PP&E Net |
0
|
4
|
3
|
2
|
0
|
|
| PP&E Gross |
0
|
0
|
3
|
2
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
2
|
0
|
1
|
2
|
|
| Total Assets |
63
N/A
|
118
+86%
|
59
-50%
|
18
-69%
|
8
-56%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
7
|
3
|
2
|
2
|
|
| Accrued Liabilities |
0
|
1
|
6
|
3
|
3
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
37
|
6
|
0
|
0
|
0
|
|
| Total Current Liabilities |
38
|
14
|
9
|
6
|
5
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
3
|
2
|
1
|
0
|
|
| Total Liabilities |
38
N/A
|
17
-54%
|
12
-33%
|
7
-40%
|
5
-25%
|
|
| Equity | ||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
17
|
56
|
121
|
159
|
189
|
|
| Additional Paid In Capital |
42
|
156
|
169
|
170
|
192
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
25
N/A
|
100
+295%
|
48
-52%
|
11
-76%
|
3
-76%
|
|
| Total Liabilities & Equity |
63
N/A
|
118
+86%
|
59
-50%
|
18
-69%
|
8
-56%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
2
|
|